Allison M. Deal

19.4k total citations · 2 hit papers
403 papers, 10.7k citations indexed

About

Allison M. Deal is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Allison M. Deal has authored 403 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Oncology, 91 papers in Pulmonary and Respiratory Medicine and 59 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Allison M. Deal's work include Cancer survivorship and care (85 papers), Childhood Cancer Survivors' Quality of Life (42 papers) and Frailty in Older Adults (39 papers). Allison M. Deal is often cited by papers focused on Cancer survivorship and care (85 papers), Childhood Cancer Survivors' Quality of Life (42 papers) and Frailty in Older Adults (39 papers). Allison M. Deal collaborates with scholars based in United States, Israel and Canada. Allison M. Deal's co-authors include Hyman B. Muss, Grant R. Williams, Kirsten A. Nyrop, Ethan Basch, Mackenzi Pergolotti, Shlomit Strulov Shachar, Antonia V. Bennett, Amylou C. Dueck, Lauren J. Rogak and Lisa A. Carey and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Allison M. Deal

377 papers receiving 10.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

2015 1.7k citations Ethan Basch, Allison M. Deal et al. profile →
Cardiac Toxicity After Radiotherapy for Stage III Non–Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy

2017 303 citations Allison M. Deal, Carrie B. Lee et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Allison M. Deal	4.8k	2.2k	1.9k	1.7k	1.7k	403	10.7k
Alice B. Kornblith	6.1k 1.3×	2.4k 1.1×	2.7k 1.4×	712 0.4×	1.1k 0.7×	109	12.5k
Chien‐Wen Tseng	3.5k 0.7×	2.4k 1.1×	2.4k 1.2×	1.2k 0.7×	1.8k 1.1×	130	14.8k
Lonneke V. van de Poll‐Franse	8.6k 1.8×	2.4k 1.1×	1.9k 1.0×	820 0.5×	2.0k 1.2×	401	14.1k
William Dale	3.0k 0.6×	2.1k 1.0×	1.8k 1.0×	2.3k 1.4×	1.3k 0.8×	267	10.0k
Hans‐Henning Flechtner	8.9k 1.9×	4.4k 2.0×	2.1k 1.1×	1.1k 0.6×	3.0k 1.8×	117	15.2k
S. Kaasa	7.3k 1.5×	3.6k 1.7×	1.7k 0.9×	991 0.6×	2.6k 1.5×	15	12.2k
Andrew Bottomley	7.1k 1.5×	4.0k 1.9×	1.9k 1.0×	634 0.4×	2.5k 1.5×	214	12.7k
N.K. Aaronson	7.6k 1.6×	4.4k 2.0×	1.9k 1.0×	1.0k 0.6×	2.7k 1.6×	25	13.4k
Stewart B. Fleishman	9.0k 1.9×	4.6k 2.1×	2.2k 1.2×	1.3k 0.8×	2.9k 1.7×	40	15.0k
Bengt Bergman	9.6k 2.0×	5.6k 2.6×	2.1k 1.1×	1.2k 0.7×	3.0k 1.8×	101	16.1k

Countries citing papers authored by Allison M. Deal

Since Specialization

Citations

This map shows the geographic impact of Allison M. Deal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison M. Deal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison M. Deal more than expected).

Fields of papers citing papers by Allison M. Deal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison M. Deal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison M. Deal. The network helps show where Allison M. Deal may publish in the future.

Co-authorship network of co-authors of Allison M. Deal

This figure shows the co-authorship network connecting the top 25 collaborators of Allison M. Deal. A scholar is included among the top collaborators of Allison M. Deal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison M. Deal. Allison M. Deal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Chelsea, Allison M. Deal, Jennifer E. Mersereau, et al.. (2025). Fertility preservation and in vitro fertilization (IVF) success rates after cancer. JNCI Cancer Spectrum. 9(4).

Stover, Angela M., Allison M. Deal, Ashley A. Weiner, et al.. (2025). Feasibility, Acceptability, and Utility of Remote Patient-Reported Outcomes Monitoring in Patients With Lung Cancer: A Moovcare© Study. Clinical Lung Cancer. 26(8). e660–e669.e1.

Kent, Erin E., et al.. (2025). Feasibility and Acceptability of an 8‐Week Supportive Care Intervention for Cancer Caregivers Adapted for Rural Settings. Psycho-Oncology. 34(12). e70341–e70341.

Nyante, Sarah J., Allison M. Deal, Hillary Heiling, et al.. (2024). Trends in breast, colon, pancreatic, and uterine cancers in women during the COVID‐19 pandemic in North Carolina. Cancer Medicine. 13(7). e7156–e7156. 2 indexed citations

Gotz, David, Hillary Heiling, Allison M. Deal, et al.. (2024). PD40-05 GIST OVERRIDES NUMERIC RISK PERCEPTION IN SURGICAL DECISION-MAKING. The Journal of Urology. 211(5S).

Almond, N. E., Allison M. Deal, Annie Page‐Karjian, Kirsten A. Nyrop, & Hyman B. Muss. (2024). Associations of social vulnerability index with patient-reported outcomes in women treated with chemotherapy for early-stage breast cancer. The Oncologist. 30(7). 1 indexed citations

Hanson, Erik D., Alexander R. Lucas, Young E. Whang, et al.. (2022). Feasibility of home-based exercise training in men with metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 26(2). 302–308. 11 indexed citations

Heiling, Hillary, Allison M. Deal, Christopher E. Jensen, et al.. (2022). Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 22(12). 920–927. 6 indexed citations

Jensen, Christopher E., Kirsten A. Nyrop, Allison M. Deal, et al.. (2022). Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life. The Oncologist. 27(8). 694–702. 6 indexed citations

10.

Nyrop, Kirsten A., Allison M. Deal, Stephanie B. Wheeler, et al.. (2021). Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer. Breast Cancer Research and Treatment. 191(2). 409–422. 15 indexed citations

11.

Weiss, Jared, Siddharth Sheth, Allison M. Deal, et al.. (2020). Concurrent Definitive Immunoradiotherapy for Patients with Stage III–IV Head and Neck Cancer and Cisplatin Contraindication. Clinical Cancer Research. 26(16). 4260–4267. 29 indexed citations

12.

Nyrop, Kirsten A., Allison M. Deal, Bryce B. Reeve, et al.. (2020). Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer. Cancer. 127(6). 957–967. 9 indexed citations

13.

Meernik, Clare, Anne C. Kirchhoff, Chelsea Anderson, et al.. (2020). Material and psychological financial hardship related to employment disruption among female adolescent and young adult cancer survivors. Cancer. 127(1). 137–148. 41 indexed citations

14.

Aleixo, Gabriel, Seul Ki Choi, Kirsten A. Nyrop, et al.. (2019). Is “Geriatric” Assessment Just for Older Patients?. The Oncologist. 25(4). 355–358. 13 indexed citations

15.

Anderson, Chelsea, Hazel B. Nichols, Allison M. Deal, Yong‐Moon Park, & Dale P. Sandler. (2018). Changes in cardiovascular disease risk and risk factors among women with and without breast cancer. Cancer. 124(23). 4512–4519. 11 indexed citations

16.

Shachar, Shlomit Strulov, Allison M. Deal, Marc S. Weinberg, et al.. (2017). Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer. Clinical Cancer Research. 23(14). 3537–3543. 121 indexed citations

17.

Crowther, Andrew, Fang Fang, Allison M. Deal, et al.. (2016). Radiation Sensitivity in a Preclinical Mouse Model of Medulloblastoma Relies on the Function of the Intrinsic Apoptotic Pathway. Cancer Research. 76(11). 3211–3223. 22 indexed citations

18.

Shachar, Shlomit Strulov, Allison M. Deal, Marc S. Weinberg, et al.. (2016). Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy. Clinical Cancer Research. 23(3). 658–665. 215 indexed citations

19.

Karginova, Olga, Marni B. Siegel, Amanda E.D. Van Swearingen, et al.. (2015). Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA -Mutated and BRCA –Wild-Type Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 14(4). 920–930. 53 indexed citations

20.

Malin, Dmitry, Elena Strekalova, Vladimír Petrovič, et al.. (2013). αB-Crystallin: A Novel Regulator of Breast Cancer Metastasis to the Brain. Clinical Cancer Research. 20(1). 56–67. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact